Franklin, IN, United States of America

Sandra Ann Filla

This inventor holds 24 USPTO granted patents and 1 published patent application and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Eli Lilly and Company, Astrazeneca Ab. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra Ann Filla. Retrieved from https://idiyas.com/inventor/sandra-ann-filla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 25.0

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 69(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1998 - 1999)
  • Ashland, MA (US) (2005)
  • Brownsburg, IN (US) (2007 - 2009)
  • Franklin, IN (US) (1999 - 2012)

Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Serotonin Reuptake Inhibitors
Excitatory Amino Acid Antagonists
5-HT7 Receptor Antagonists
5-HT1F Agonists
Fused Heterocyclics
Propanamine Derivatives
Migraine Treatment
Neurological Disorders
Selective iGluR5 Antagonists
Aryloxy Propanamines
Heteroaromatic Compounds
24 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Sandra Ann Filla

Introduction

Sandra Ann Filla is a distinguished inventor based in Franklin, Indiana, with an impressive portfolio of 24 patents. Her contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various health conditions, have garnered significant attention and respect within the scientific community.

Latest Patents

Among her latest patents, Sandra has developed innovative compounds such as 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines, which function as selective 5-HT7 receptor antagonists. This invention is aimed at providing effective treatment options for conditions such as migraine, persistent pain, and anxiety. The compounds feature a detailed formula where parameters like A and B are each defined as either a specific carbon or nitrogen structure within the synthesis. Additionally, she has patented a serotonin and norepinephrine reuptake inhibitor with a specific formula, focusing on its uses and preparation methods, further expanding the scope of pharmacological treatments.

Career Highlights

Throughout her career, Sandra has been associated with major pharmaceutical companies, including Eli Lilly and Company and AstraZeneca. Her work in these organizations has facilitated the advancement of medical solutions and has positioned her as a key player in drug development.

Collaborations

During her journey, Sandra has collaborated with notable coworkers, including Brian Michael Mathes and John M Schaus. These partnerships have contributed to the research and development of innovative solutions in pharmacology, emphasizing the importance of teamwork in successful invention.

Conclusion

Sandra Ann Filla's trailblazing work in the development of medications demonstrates her commitment to improving healthcare through innovation. Her extensive patent portfolio reflects not only her creativity and technical skills but also her dedication to finding effective treatments for challenging medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…